COMMUNIQUÉS West-GlobeNewswire

Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events
04/01/2019
Company to Release New Survey Findings from C-Suite Leaders on Commercial Spend and Planning and Essentials for a Successful Launch MORRISVILLE, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the [...]
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System
04/01/2019
ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 woman in the BLOC [...]
OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Belgium and the Netherlands
04/01/2019
WARSAW, Ind., Jan. 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today their recently [...]
HMS Hires Robert P. Borchert as New Investor Relations Officer
04/01/2019
IRVING, Texas, Jan. 04, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp (Nasdaq:HMSY) today announced that Robert P. Borchert has joined the Company as Senior Vice President, Investor Relations. He succeeds Dennis Oakes, who [...]
Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
Industry’s Largest Symposium Brings Over 9,000 Attendees to San Francisco CHARLOTTESVILLE, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company [...]
La Jolla Pharmaceutical Company to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Affimed to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
Heidelberg, Germany, January 4, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to improving patient outcomes through the power of the innate immune system, today announced that [...]
Tauriga Sciences Inc. Reveals Several of the Specific & Differentiating Features Integrated into its Cannabis/CBD Infused Chewing Gum Product Line
04/01/2019
New York, NY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
04/01/2019
DTX401 Response Observed in All Three Patients, with Two Patients Demonstrating Clinically Meaningful Improvement in Time to Hypoglycemia Study to Advance to Cohort 2 at a Higher Dose NOVATO, Calif., Jan. 04, 2019 ( [...]
Resonant Inc. to Present at the 21st Annual Needham Growth Conference
04/01/2019
GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]
BioCryst Appoints Steve Aselage to Board of Directors
04/01/2019
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed Steve Aselage to its board of directors. Mr. Aselage most [...]
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board
04/01/2019
CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease
04/01/2019
ZUG, Switzerland and CAMBRIDGE, Mass. and BOSTON, Jan. 04, 2019 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) today announced that the U.S. Food and Drug [...]
Dr. Henry Ji to Participate In Financing Expert Panel at East/West CEO Conference
04/01/2019
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today that Dr. Henry Ji, Chairman and CEO, will participate in the East/West CEO conference in San Francisco [...]
Mersana Therapeutics Announces Strategic Priorities and Goals for 2019 and Beyond
04/01/2019
Company to Focus its Resources on Advancing XMT-1536, its First-in-Class ADC Candidate Targeting NaPi2b, Showing Encouraging Early Signs of Efficacy Dose Selection and Initiation of XMT-1536 Expansion Cohorts on Track [...]
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO™ to Treat Complicated Urinary Tract Infections by FDA
04/01/2019
-PDUFA action date set for June 30, 2019- DUBLIN, Ireland, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of [...]
Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO
04/01/2019
GAITHERSBURG, Md., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its CEO Daniel J. Abdun-Nabi will be retiring and that its board of directors has unanimously appointed [...]
OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance
04/01/2019
CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics Novosanis’ urine collection technology expands [...]
Vistin Pharma ASA : Trading update for Energy Trading
04/01/2019
Oslo, Norway, 4 January 2019 Reference is made to the announcement yesterday regarding the resignation of Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA ("Vistin Pharma" or the "Company"). The Company is in [...]

Pages